Phase 2 biotech developing therapies for cancer.
Industry: Health Care
Latest Trade: $1.72 0.00 (0.0%)
First Day Return: -35.0%
Return from IPO: -57.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/29/2023 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/16/2024 |
Offer Price | $4.00 |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Boustead Securities |
D. Boral Capital |
more |
Company Data | |
---|---|
Headquarters | Los Angeles, CA, United States |
Founded | 2013 |
Employees at IPO | 3 |
Website www.kairospharma.com |